Search Result "M2000"
The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 13 Issue: 1 Year: 2019 Page: 57-65
Author(s): Laleh Sharifi,Mona Moshiri,Mohammad M.S. Dallal,Mohammad H. Asgardoon,Maryam Nourizadeh,Saied Bokaie,Abbas Mirshafiey
Modification of Sexual Hormones in Rheumatoid Arthritis Patients by M2000 (β-D-mannuronic Acid) as a Novel NSAID with Immunosuppressive Property
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 18 Issue: 5 Year: 2018 Page: 530-536
Author(s): Mozhgan Jahanbakhshi,Zohreh Babaloo,Seyed Shahabeddin Mortazavi-Jahromi,Maryam Monsef Shokri,Hossein Ahmadi,Abbas Mirshafiey
M2000, Foundation of a New Generation Among NSAIDs
Journal: Letters in Drug Design & Discovery
Volume: 2 Issue: 5 Year: 2005 Page: 412-423
Author(s): A. Mirshafiey, B. Rehm, S. Cuzzocrea, H. Matsuo, E. Mazzon, S. Nakane, C- S. Koh, S. Miyoshi
The Anti-Migraine Effects of M2000 (β-D-Mannuronic Acid) on a Patient with Rheumatoid Arthritis: Case Report
Journal: Current Clinical Pharmacology
Volume: 12 Issue: 2 Year: 2017 Page: 127-130
Author(s): Mahdi Vojdanian,Hossein Ahmadi,Ahmad Reza Jamshidi,Mahdi Mahmoudi,Farhad Gharibdoost,Anis Barati,Abbas Mirshafiey
The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis
Journal: Current Drug Discovery Technologies
Volume: 14 Issue: 3 Year: 2017 Page: 206-214
Author(s): Hossein Ahmadi,Ahmad R. Jamshidi,Mahdi Mahmoudi,Salvatore Cuzzocrea,Mohammad Javad Fattahi,Anis Barati,Bernd H. A. Rehm,Hidenori Matsuo,Abbas Mirshafiey
β-D-Mannuronic Acid (M2000) as a Landmark in Pharmacology
Journal: Current Drug Discovery Technologies
Volume: 18 Issue: 1 Year: 2021 Page: 47-57
Author(s): Nada A.G. Gaafar,Alireza Razavi,Abbas Mirshafiey
The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients
Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 5 Year: 2020 Page: 704-710
Author(s): Nada A.G. Gaafar,Mona Aslani,Zahra Aghazadeh,Alireza Razavi,Abbas Mirshafiey
Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC
Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 2 Year: 2020 Page: 225-232
Author(s): Atousa Khalatbari,Mehdi Mahdavi,Fahimeh Jafarnezhad,Sanaz Afraei,Farzaneh Tofighi Zavareh,Zahra Aghazadeh,Afshin Ghaderi,Abbas Mirshafiey
The Safety Property of β-D-Mannuronic Acid (M2000) as a Novel Immunosuppressive Agent on Differentiation, Maturation and Function of Human Dendritic Cells
Journal: Current Drug Discovery Technologies
Volume: 13 Issue: 3 Year: 2016 Page: 164-169
Author(s): Nazanin A. Fard,Nakisa Tabrizian,Reza Mirzaei,Nasrin Motamed,Farzaneh T. Zavareh,Abbas Mirshafiey
The Biology of β-D-mannuronic acid (M2000) on Human Dendritic Cell Based on MicroRNA-155 and MicroRNA-221
Journal: Current Drug Discovery Technologies
Volume: 14 Issue: 1 Year: 2017 Page: 53-58
Author(s): Nakisa Tabrizian,Nazanin Arjomand Fard,Ali Farazmand,Rahil Eftekhari,Farzaneh Tofighi Zavareh,Abbas Mirshafiey